Correlation Between Madrigal Pharmaceuticals and Xilio Development
Can any of the company-specific risk be diversified away by investing in both Madrigal Pharmaceuticals and Xilio Development at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Madrigal Pharmaceuticals and Xilio Development into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Madrigal Pharmaceuticals and Xilio Development, you can compare the effects of market volatilities on Madrigal Pharmaceuticals and Xilio Development and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Madrigal Pharmaceuticals with a short position of Xilio Development. Check out your portfolio center. Please also check ongoing floating volatility patterns of Madrigal Pharmaceuticals and Xilio Development.
Diversification Opportunities for Madrigal Pharmaceuticals and Xilio Development
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Madrigal and Xilio is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Madrigal Pharmaceuticals and Xilio Development in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xilio Development and Madrigal Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Madrigal Pharmaceuticals are associated (or correlated) with Xilio Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xilio Development has no effect on the direction of Madrigal Pharmaceuticals i.e., Madrigal Pharmaceuticals and Xilio Development go up and down completely randomly.
Pair Corralation between Madrigal Pharmaceuticals and Xilio Development
Given the investment horizon of 90 days Madrigal Pharmaceuticals is expected to generate 0.64 times more return on investment than Xilio Development. However, Madrigal Pharmaceuticals is 1.55 times less risky than Xilio Development. It trades about 0.34 of its potential returns per unit of risk. Xilio Development is currently generating about -0.02 per unit of risk. If you would invest 21,700 in Madrigal Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 12,818 from holding Madrigal Pharmaceuticals or generate 59.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Madrigal Pharmaceuticals vs. Xilio Development
Performance |
| Timeline |
| Madrigal Pharmaceuticals |
| Xilio Development |
Madrigal Pharmaceuticals and Xilio Development Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Madrigal Pharmaceuticals and Xilio Development
The main advantage of trading using opposite Madrigal Pharmaceuticals and Xilio Development positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Madrigal Pharmaceuticals position performs unexpectedly, Xilio Development can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xilio Development will offset losses from the drop in Xilio Development's long position.| Madrigal Pharmaceuticals vs. Eliem Therapeutics | Madrigal Pharmaceuticals vs. HCW Biologics | Madrigal Pharmaceuticals vs. Scpharmaceuticals | Madrigal Pharmaceuticals vs. Milestone Pharmaceuticals |
| Xilio Development vs. Connect Biopharma Holdings | Xilio Development vs. Tyra Biosciences | Xilio Development vs. RAPT Therapeutics | Xilio Development vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |